This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Elsevier Introduces EBook Library Of Health And Medical Books For Lecturers, Librarians And Medical Students In South-East Asia

SINGAPORE, April 28, 2014 /PRNewswire/ --

Accessible on computer and mobile devices, medical book content available 24/7 with advanced search capability providing access to important healthcare information on the go 

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the availability of Elsevier eLibrary, an e-book platform designed to help increase the productivity and efficiency of health lecturers, librarians and students. The platform will be available in South-East Asia as a pilot, and will be presented throughout Asia Pacific in the near future.

The Elsevier eLibrary delivers educational health and medical materials whenever and wherever it's required, on any device, on and offline.

"As a leading global provider of digital information solutions, Elsevier is leveraging the power of technology to provide an alternative delivery option of our quality content and information to the next generation of health and medical professionals," said Gerrit Bos, Elsevier's Managing Director of Health Solutions for Asia Pacific. "We want to provide today's tech-savvy lecturers and students with the ability to access their textbooks at any time from any device."    

The Elsevier eLibrary offers clear and obvious benefits to an institution and its constituents:

Lecturers

  • Advanced search capability improves efficiency when creating problem-based or scenario-based curriculum
  • Built-in functionalities allows creative development of classroom resources
  • Access to multiple eBooks helps expand content to aid additional reading and cross-referencing

Librarians

  • Built-in usage reports help manage and balance ROI
  • Quicker search for recommended texts
  • Provide students an alternative resource delivery to learn the way they choose to

Students

  • Trusted health and medical content on the go on any Internet device
  • Quicker access to content and information via an efficient search engine
  • Personalization of course notes through added functionalities

For a free 30-day trial of the Elsevier eLibrary, visit http://www.elsevier-elibrary.com or email salesop@elsevier.com.

For  Malaysia   Press: Visit the Elsevier booth at Kuala Lumpur International Book Fair from 24 April to 4 May to experience Elsevier eLibrary for yourself and get a 30-day free trial.

About Elsevier 

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey - and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world-leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact Jason Chan Director, Corporate Relations, Asia Pacific Elsevier +65-63490240 j.chan@elsevier.com

SOURCE Elsevier

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,172.68 -107.06 -0.62%
S&P 500 1,994.29 -16.11 -0.80%
NASDAQ 4,527.6890 -52.10 -1.14%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs